Study findings indicated a transition from IV to enteral triazole therapy as a feasible option for pediatric patients with invasive candidiasis.

Pediatr Crit Care Med. 2013;14(6):e268-72. IV colistin was well tolerated in most of our critically ill children, and only five children had development of renal impairment after starting colistin ...

Background and aims: The aim is to evaluate and compare the efficacy and side effects of oral and intravenous(IV) ibuprofen for treatment of PDA in preterm infants. Methods: A prospective ...

According to Celltrion, STEQEYMA is expected to be marketed in the United States beginning in February 2025. DISCLAIMER: Because of the generality of this update, the information provided herein may ...